Cargando…

Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS)

PURPOSE: The Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) is an ongoing prospective cohort created by the Geneva Directorate of Health. It consists of an operational database compiling all SARS-CoV-2 test results recorded in the Geneva area since late February 202...

Descripción completa

Detalles Bibliográficos
Autores principales: Genecand, Camille, Mongin, Denis, Koegler, Flora, Lebowitz, Dan, Regard, Simon, Falcone, Jean-Luc, Nehme, Mayssam, Braillard, Olivia, Grira, Marwène, Joubert, Dominique, Chopard, Pierre, Delaporte, Elisabeth, Stirnemann, Jérôme, Guessous, Idris, Tardin, Aglaé, Courvoisier, Delphine S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634627/
https://www.ncbi.nlm.nih.gov/pubmed/34848509
http://dx.doi.org/10.1136/bmjopen-2021-048946
_version_ 1784608158276124672
author Genecand, Camille
Mongin, Denis
Koegler, Flora
Lebowitz, Dan
Regard, Simon
Falcone, Jean-Luc
Nehme, Mayssam
Braillard, Olivia
Grira, Marwène
Joubert, Dominique
Chopard, Pierre
Delaporte, Elisabeth
Stirnemann, Jérôme
Guessous, Idris
Tardin, Aglaé
Courvoisier, Delphine S
author_facet Genecand, Camille
Mongin, Denis
Koegler, Flora
Lebowitz, Dan
Regard, Simon
Falcone, Jean-Luc
Nehme, Mayssam
Braillard, Olivia
Grira, Marwène
Joubert, Dominique
Chopard, Pierre
Delaporte, Elisabeth
Stirnemann, Jérôme
Guessous, Idris
Tardin, Aglaé
Courvoisier, Delphine S
author_sort Genecand, Camille
collection PubMed
description PURPOSE: The Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) is an ongoing prospective cohort created by the Geneva Directorate of Health. It consists of an operational database compiling all SARS-CoV-2 test results recorded in the Geneva area since late February 2020. This article aims at presenting this comprehensive cohort, in light of some of the varying public health measures in Geneva, Switzerland, since March 2020. PARTICIPANTS: As of 1 June 2021, the database included 360 525 patients, among which 65 475 had at least one positive test result for SARS-CoV-2. Among all positive patients, 37.6% were contacted only once, 10.6% had one follow-up call, 8.5% had two and 27.7% had three or more follow-up calls. Participation rate among positive patients is 94%. Data collection is ongoing. FINDINGS TO DATE: ARGOS data illustrates the magnitude of COVID-19 pandemic in Geneva, Switzerland, and details a variety of population factors and outcomes. The content of the cohort includes demographic data, comorbidities and risk factors for poor clinical outcome, self-reported COVID-19 symptoms, environmental and socioeconomic factors, prospective and retrospective contact tracing data, travel quarantine data and deaths. The registry has already been used in several publications focusing on symptoms and long COVID-19, infection fatality rate and re-infection. FUTURE PLANS: The data of this large real-world registry provides a valuable resource for various types of research, such as clinical research, epidemiological research or policy assessment as it illustrates the impact of public health policies and overall disease burden of COVID-19.
format Online
Article
Text
id pubmed-8634627
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86346272021-12-01 Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) Genecand, Camille Mongin, Denis Koegler, Flora Lebowitz, Dan Regard, Simon Falcone, Jean-Luc Nehme, Mayssam Braillard, Olivia Grira, Marwène Joubert, Dominique Chopard, Pierre Delaporte, Elisabeth Stirnemann, Jérôme Guessous, Idris Tardin, Aglaé Courvoisier, Delphine S BMJ Open Epidemiology PURPOSE: The Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS) is an ongoing prospective cohort created by the Geneva Directorate of Health. It consists of an operational database compiling all SARS-CoV-2 test results recorded in the Geneva area since late February 2020. This article aims at presenting this comprehensive cohort, in light of some of the varying public health measures in Geneva, Switzerland, since March 2020. PARTICIPANTS: As of 1 June 2021, the database included 360 525 patients, among which 65 475 had at least one positive test result for SARS-CoV-2. Among all positive patients, 37.6% were contacted only once, 10.6% had one follow-up call, 8.5% had two and 27.7% had three or more follow-up calls. Participation rate among positive patients is 94%. Data collection is ongoing. FINDINGS TO DATE: ARGOS data illustrates the magnitude of COVID-19 pandemic in Geneva, Switzerland, and details a variety of population factors and outcomes. The content of the cohort includes demographic data, comorbidities and risk factors for poor clinical outcome, self-reported COVID-19 symptoms, environmental and socioeconomic factors, prospective and retrospective contact tracing data, travel quarantine data and deaths. The registry has already been used in several publications focusing on symptoms and long COVID-19, infection fatality rate and re-infection. FUTURE PLANS: The data of this large real-world registry provides a valuable resource for various types of research, such as clinical research, epidemiological research or policy assessment as it illustrates the impact of public health policies and overall disease burden of COVID-19. BMJ Publishing Group 2021-11-30 /pmc/articles/PMC8634627/ /pubmed/34848509 http://dx.doi.org/10.1136/bmjopen-2021-048946 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Genecand, Camille
Mongin, Denis
Koegler, Flora
Lebowitz, Dan
Regard, Simon
Falcone, Jean-Luc
Nehme, Mayssam
Braillard, Olivia
Grira, Marwène
Joubert, Dominique
Chopard, Pierre
Delaporte, Elisabeth
Stirnemann, Jérôme
Guessous, Idris
Tardin, Aglaé
Courvoisier, Delphine S
Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS)
title Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS)
title_full Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS)
title_fullStr Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS)
title_full_unstemmed Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS)
title_short Cohort profile: Actionable Register of Geneva Outpatients and inpatients with SARS-CoV-2 (ARGOS)
title_sort cohort profile: actionable register of geneva outpatients and inpatients with sars-cov-2 (argos)
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634627/
https://www.ncbi.nlm.nih.gov/pubmed/34848509
http://dx.doi.org/10.1136/bmjopen-2021-048946
work_keys_str_mv AT genecandcamille cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT mongindenis cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT koeglerflora cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT lebowitzdan cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT regardsimon cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT falconejeanluc cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT nehmemayssam cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT braillardolivia cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT griramarwene cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT joubertdominique cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT chopardpierre cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT delaporteelisabeth cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT stirnemannjerome cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT guessousidris cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT tardinaglae cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos
AT courvoisierdelphines cohortprofileactionableregisterofgenevaoutpatientsandinpatientswithsarscov2argos